Latest eBooks

Download this eBook to learn more about how to link genomics with proteomics to accelerate the search for drug targets, understand COVID-Associated Multisystem Inflammatory Syndrome in children and much more.

In honor of International Day of Women and Girls in Science 2022, we interviewed female scientists working across numerous fields, to learn about their experiences and hear words of wisdom gathered during their careers.

In medicine, gene therapy is the process where nucleic acids are delivered to a patient’s cells as a therapeutic drug to treat an array of genetic diseases. All gene therapies utilize either viral or non-viral vectors to deliver the DNA or RNA into the host cell.

Download this eBook to explore a collection of news, articles, interviews and infographics published in 2021, handpicked by the publication’s editorial team.

Technological advances along with developments in molecular medicine and data science have fueled the exploration of personalized medicine, as a result, several fields are already benefiting. Download this eBook to learn more about the topic.

Cancer is reshaping our families, our communities and our world. It is among the leading causes of death globally and cancer rates are increasing for nearly every age group and indication. Despite its prevalence, there is so much left to reveal.

Download this eBook to learn more about the fight against infectious disease, bridging the gap between immune response and treatment development plus much more.

The term proteomics – used to describe the large-scale characterization of proteins – was coined in the 1990s by Mark Wilkins, who was a PhD student at the time. Download this eBook to learn more about recent developments in proteomics research.

The use of organoids, self-organized three-dimensional (3D) assemblies of cells, as research tools has become more common due to their ability to better recapitulate human disease compared to more traditional models.

Every field of biology has a moonshot vision. Whether that be identifying a new cell type in a poorly characterized tissue, finding a lasting, effective drug target for Alzheimer’s disease or reaching 100% remission rates for immunotherapy across patients and cancer types.